PURPOSE: The purpose of this study was to establish the degree of compliance with the fast track (enhanced recovery) protocol in habitual clinical practice and to determine which measures are fundamental for achieving the results obtained by applying the entire protocol. METHODS: Observational, cross-sectional, multicenter trial was conducted. Participating hospitals prospectively recorded data from at least ten consecutive patients undergoing surgery for colon cancer who were applied some or all of the items comprising the enhanced recovery protocol. The data were analyzed both globally and dividing the sample into the two groups of patients. RESULTS: Data on 363 patients from 25 hospitals were recorded, one hundred seventy-three in the "non-fast track" group and 190 in the "fast track" group. The non-fast track group complied with a mean of 5.4 (±1.8) items and the fast track group with a mean of 8.4 (±1.8) items. The mean functional hospital stay was 7.3 (±5.1) days in the non-fast track group and 6.2 (±5.1) days in the fast track group (p < 0.05). Morbidity was 31.1 % in the fast track group and 24.3 % in the non-fast track group, though the differences were not statistically significant. The only prognostic factors that have an impact on improving the results are measures against hypothermia and mobilization before 24 h. CONCLUSION: Compliance with the enhanced recovery protocol is not exhaustive in habitual clinical practice. However, greater compliance was associated with shorter hospital stay without any increase in morbidity. The only items clearly associated with reduced functional hospital stay were measures against hypothermia and mobilization before 24 h.
PURPOSE: The purpose of this study was to establish the degree of compliance with the fast track (enhanced recovery) protocol in habitual clinical practice and to determine which measures are fundamental for achieving the results obtained by applying the entire protocol. METHODS: Observational, cross-sectional, multicenter trial was conducted. Participating hospitals prospectively recorded data from at least ten consecutive patients undergoing surgery for colon cancer who were applied some or all of the items comprising the enhanced recovery protocol. The data were analyzed both globally and dividing the sample into the two groups of patients. RESULTS: Data on 363 patients from 25 hospitals were recorded, one hundred seventy-three in the "non-fast track" group and 190 in the "fast track" group. The non-fast track group complied with a mean of 5.4 (±1.8) items and the fast track group with a mean of 8.4 (±1.8) items. The mean functional hospital stay was 7.3 (±5.1) days in the non-fast track group and 6.2 (±5.1) days in the fast track group (p < 0.05). Morbidity was 31.1 % in the fast track group and 24.3 % in the non-fast track group, though the differences were not statistically significant. The only prognostic factors that have an impact on improving the results are measures against hypothermia and mobilization before 24 h. CONCLUSION: Compliance with the enhanced recovery protocol is not exhaustive in habitual clinical practice. However, greater compliance was associated with shorter hospital stay without any increase in morbidity. The only items clearly associated with reduced functional hospital stay were measures against hypothermia and mobilization before 24 h.
Authors: D J Schoetz; M Bockler; M S Rosenblatt; S Malhotra; P L Roberts; J J Murray; J A Coller; L C Rusin Journal: Dis Colon Rectum Date: 1997-07 Impact factor: 4.585
Authors: Henrik Kehlet; Markus W Büchler; Robert W Beart; Richard P Billingham; Russell Williamson Journal: J Am Coll Surg Date: 2005-10-20 Impact factor: 6.113
Authors: J Maessen; C H C Dejong; J Hausel; J Nygren; K Lassen; J Andersen; A G H Kessels; A Revhaug; H Kehlet; O Ljungqvist; K C H Fearon; M F von Meyenfeldt Journal: Br J Surg Date: 2007-02 Impact factor: 6.939
Authors: Arman Kahokehr; Tarik Sammour; Kamran Zargar-Shoshtari; Lisa Thompson; Andrew G Hill Journal: Int J Surg Date: 2008-12-03 Impact factor: 6.071
Authors: Kristoffer Lassen; Mattias Soop; Jonas Nygren; P Boris W Cox; Paul O Hendry; Claudia Spies; Maarten F von Meyenfeldt; Kenneth C H Fearon; Arthur Revhaug; Stig Norderval; Olle Ljungqvist; Dileep N Lobo; Cornelis H C Dejong Journal: Arch Surg Date: 2009-10
Authors: Silvia Salvans; María José Gil-Egea; María Angeles Martínez-Serrano; Elionor Bordoy; Sandra Pérez; Marta Pascual; Sandra Alonso; David Parés; Ricard Courtier; Miguel Pera; Luis Grande Journal: Cir Esp Date: 2010-07-02 Impact factor: 1.653
Authors: Krishna K Varadhan; Keith R Neal; Cornelius H C Dejong; Kenneth C H Fearon; Olle Ljungqvist; Dileep N Lobo Journal: Clin Nutr Date: 2010-01-29 Impact factor: 7.324
Authors: Ruben van Zelm; Ellen Coeckelberghs; Walter Sermeus; Anthony De Buck van Overstraeten; Arved Weimann; Deborah Seys; Massimiliano Panella; Kris Vanhaecht Journal: Int J Colorectal Dis Date: 2017-07-17 Impact factor: 2.571
Authors: Rebecca K Marcus; Heather A Lillemoe; David C Rice; Gabriel Mena; Brian K Bednarski; Barbra B Speer; Pedro T Ramirez; Javier D Lasala; Neema Navai; Wendell H Williams; Bradford J Kim; Rachel K Voss; Vijaya N Gottumukkala; Thomas A Aloia Journal: Ann Surg Oncol Date: 2019-01-09 Impact factor: 5.344
Authors: Vijaya Gottumukkala; Thomas A Aloia; Ryan W Day; Sharon Fielder; John Calhoun; Henrik Kehlet Journal: Br J Surg Date: 2015-09-14 Impact factor: 6.939
Authors: Michał Pędziwiatr; Magdalena Pisarska; Michał Kisielewski; Maciej Matłok; Piotr Major; Mateusz Wierdak; Andrzej Budzyński; Olle Ljungqvist Journal: Med Oncol Date: 2016-02-12 Impact factor: 3.064
Authors: Ellen Coeckelberghs; Kris Vanhaecht; Deborah Seys; Bianca Cox; Gabriele Bislenghi; Albert M Wolthuis; André D'Hoore Journal: Ann Surg Date: 2022-08-02 Impact factor: 13.787